Results 161 to 170 of about 9,592 (241)

The effect of HFE gene mutation and iron overload on sustained virological response in Egyptian chronic hepatitis C patients treated with daclatasvir and sofosbuvir. [PDF]

Korean J Intern Med
Kodsi EM, Ismail H, Issa R, Elshaarawy A, Sakr MA, Shehata EL, Issak ER.   +6 more
europepmc   +1 more source

Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter study

, 2017
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung, Makoto Kako   +14 more
openalex   +1 more source

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir [PDF]

, 2017
Ayumi Sugiura, Shuichi Wada, Hiromitsu Mori, Takefumi Kimura, Yoshiaki Matsuda, Naoki Tanaka, Eiji Tanaka, Kendo Kiyosawa   +7 more
openalex   +1 more source

Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study. [PDF]

Medicine (Baltimore)
Sung BR, Shim SG, Kim KM, Lee JW, Kim JY, Lee BK, Jun CH, Kwan BS.   +7 more
europepmc   +1 more source

Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C

, 2016
Spilios Manolakopoulos
openalex   +1 more source

The hepatitis C virus NS5A inhibitor daclatasvir has a dual mode of action and leads to a new virus half-life estimate

, 2013
Jérémie Guedj, Harel Dahari, Susan L. Uprichard, Alan S. Perelson   +3 more
openalex   +2 more sources

Single-cell analysis of heterogeneity in reverted hiPSC-derived human hepatic stellate cells. [PDF]

JHEP Rep
Wang X, Ha EH, Bian L, Feng Z, Zhang F, O'Shaughnessy K, Wang L, Hochwald A, Zheng Y, Chen W, Zhang Y, Wu X.   +11 more
europepmc   +1 more source

Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus

, 2016
Ken Sato, Yuichi Yamazaki, Tatsuya Ohyama, Takeshi Kobayashi, Norio Horiguchi, Satoru Kakizaki, Motoyasu Kusano, Masanobu Yamada   +7 more
openalex   +2 more sources

Chronic blood-borne viral hepatitis in a tertiary hospital in Al-Baha, Saudi Arabia: epidemiology, liver enzyme correlations, and treatment outcomes. [PDF]

BMC Infect Dis
Sallam TA, El-Badry RM, Alkully TH, Alfahemi HH, Halwani MA, Alzahrani KI, Alghamdi MA.   +6 more
europepmc   +1 more source

Sustained virological response after only 5 weeks treatment with daclatasvir/pegylated interferon and ribavirin as part of a clinical trial in a cirrhotic human immunodeficiency virus (HIV) - hepatitis C virus (HCV) co-infected patient with liver decompensation during treatment [PDF]

, 2015
Stuart Flanagan, Athavan Umaipalan, Guy Baily, Chloe Orkin   +3 more
openalex   +1 more source